RT @SagittariusHH: HCQ fin de partie, épisode 36
@jaketapper the statement that hydroxychloroquine prevents COVID19? Our RCT just published suggests this is not supported by the science: https://t.co/b7xXMWSXCw
RT @mellziland: Mais dados para se somar a MUITOS dados mostrando que a hidroxicloroquina não funciona
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @One_Health_In: Will hydroxychloroquine "reduce the transmission of severe acute respiratory syndrome #coronavirus 2 (#SARSCoV2) as a pr…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @daniel_kraft: Hydroxychloroquine no more effective than placebo in preventing #COVID19 https://t.co/OZeIGM4g8w Randomized study of fro…
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @daniel_kraft: Hydroxychloroquine no more effective than placebo in preventing #COVID19 https://t.co/OZeIGM4g8w Randomized study of fro…
RT @docanoopmisra: Prophylaxis with #HCQ fails: In this randomized clinical trial, although limited by early termination, there was no clin…
Will hydroxychloroquine "reduce the transmission of severe acute respiratory syndrome #coronavirus 2 (#SARSCoV2) as a pre-exposure prophylaxis strategy when taken by hospital-based #healthcareworkers?" Find out👇 @JAMAInternalMed https://t.co/JxqbAkBPyo
RT @omendiz: No sirvió para prevenir Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Hea…
La #hidroxicloroquina sigue sin mostrar resultados positivos contra el #coronavirus 🦠 Un estudio publicado en la revista @JAMA_current confirma que el medicamento contra la #malaria es inefectivo para prevenir la infección por #COVID19 https://t.co/hwfD6hd
RT @Links_Medicus: Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers – via…
@BasnyatBuddha @LamichhaneN @MailOnline One RCT has just been published (it is mentioned in the article you shared). Sadly no evidence of HCQ preventing COVID19 in HCWs. This one is smaller than COPCOV so lets see.... https://t.co/r5PnptLt2T
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @Links_Medicus: Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers – via…
RT @MirkoCiminiello: Follow & RT, please. #coronavirus https://t.co/lnAo0Qmbat
Follow & RT, please. #coronavirus https://t.co/lnAo0Qmbat
Il est possible de faire un essai hcq vs placebo ! Et devinez quoi ? ... Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/PMpjFRqbr4 via @JAMAInternalMed part of @JAMANetwork
RT @Links_Medicus: Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers – via…
Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers – via @JAMAInternalMed https://t.co/vSYi40SY53 Commentary: https://t.co/WsrhiEiibR
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @joseramosvivas: Ensayo clínico pre-exposición en #sanitarios: La hidroxicloroquina no protege del #coronavirus ni aunque te construyas…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/a43XtyHpCj
HCQ Prophylactic Use Ineffective: @richardursomd @JamesTodaroMD @RatioScientiae @drsimonegold @stella_immanuel @elonmusk @sid2001 https://t.co/5OJ2va5Zjy
#HCQFAILS Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/TDH1mTiyKQ
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @EMSwami: HCQ still doesn't work for prophylaxis https://t.co/U4qiZDCAuv Infection rate in both HCQ + placebo group ~ 6.5% Excellent w…
Et oui Gérald. L'hydroxychloroquine dans le #Covid19, c'est comme l'homéopathie, ça ne marche pas, même en préventif.
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla? https://t.co/vpFi4pDEIS
RT @docanoopmisra: Prophylaxis with #HCQ fails: In this randomized clinical trial, although limited by early termination, there was no clin…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/qVx6VU2l3k via @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers https://t.co/pAPn1O4202
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @NassMeryl: Another overdose study. HCQ 600 mg/day for treatment (about 10x what is used in India), guaranteed to cause side effects th…
RT @NassMeryl: Look up the acceptable doses, Isabelle, then decide if overdosing subjects is a privilege. 1200 mg/d for rx (2-3x std dose)…
RT @SagittariusHH: HCQ fin de partie, épisode 36
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @iic_a: Satu lagi hasil uji klinis (RCT). Pemakaian secara prophylactic Hydroxychloroquine TIDAK mencegah infeksi dengan SARS-CoV2. htt…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
@realDonaldtrump's magical drug #hydroxychloroquine shown yet again to not prevent #COVID19 infections. Guess that means we're back to #InjectYourselfWithBleach and #InjectYourselfWithUVLight https://t.co/xeaF5aA0lV
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @docanoopmisra: Prophylaxis with #HCQ fails: In this randomized clinical trial, although limited by early termination, there was no clin…
RT @FormigaFrancesc: NOT DOUBTS¡ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health…
@ISPY24182540 Well we now have yet more conclusive proof #Hydroxychloroquine doesn't work, in this case as a prophylaxis treatment for healthcare workers. https://t.co/yMRIC0vm72
@niro60487270 @gummibear737 Well we now have yet more conclusive proof #Hydroxychloroquine doesn't work, in this case as a prophylaxis treatment for healthcare workers. https://t.co/yMRIC0vm72
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
Prophylaxis with #HCQ fails: In this randomized clinical trial, although limited by early termination, there was no clinical benefit of #hydroxychloroquine for 8 weeks as pre-exposure prophylaxis in health care workers exposed to patients with #COVID-19.
Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/pfwupUxoRI via @JAMAInternalMe
RT @adamwolach: @boulware_dr @_MiguelHernan @jwato_watson @xabieradrian @oriolmitja For convenience https://t.co/A3lrRfga3V
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/xWfAqSCcnr
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Ainda na onda da Hidroxicloroquina, mais um estudo randomizado controle. Dessa vez avaliando o uso profilático. Mais uma vez, sem resultados positivos... Nenhum efeito benéfico no uso do fármaco contra covid ... https://t.co/FreUNbtVGg via @JAMAInternalMe
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona.
RT @SagittariusHH: HCQ fin de partie, épisode 36
Apesar do tamanho amostral ñ ter poder estatístico p/ identificar uma possível diferença estatisticamente significativa,os resultados não sugerem q a estratégia de profilaxia pré exposição c/ HCQ possa ter papel relevante na proteção dos profissionais da s
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @drilkerbelek: JAMA Dergisinde 30 Eylül'de yayımlanan bir hidroksiklorokinin hastane çalışanlarını Covid-19'dan korumadığını gösteriyor.…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @SagittariusHH: HCQ fin de partie, épisode 36 https://t.co/dhT2syYAKT
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
JAMA Dergisinde 30 Eylül'de yayımlanan bir hidroksiklorokinin hastane çalışanlarını Covid-19'dan korumadığını gösteriyor. Trump da bu ilacı kullandığını böbürlenerek açıklamıştı. https://t.co/0LjOjRrBQd
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
How many people must be involved to repeatedly design fraudulent tests of H C Q efficacy? How many thousands have died? It shakes your faith in humanity!
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @docmmiller: Letting the science speak before politics. Gold std study DB RCT shows that #Hydroxychloroquine offers no benefits in #SARS…
HCQ fin de partie, épisode 36
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Et encore une étude. Donc HCQ ça fonctionne pas en prophylaxie, en précoce, en tardif, associé ou non à AZT. Et avec plus d'effets secondaires. Donc ça y est c'est bon, on tourne la page une bonne fois.
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @mvholmes: Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mry…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…